TrialThe journal of prevention of Alzheimer's disease2024

Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease.

W R Galpern et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.